Comparing the intervention of post operative pain for two drugs as a additive in ultrasound guided neck block among participants

Comparison of post operative analgesic efficacy of dexmedetomidine versus dexamethasone as an adjuvant in ultrasound guided bilateral superficial cervical block for thyroid surgeries-A randomised control trial - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2024/05/066752

Enrollment

Registered

2024-05-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: Z768- Persons encountering health services in other specified circumstances

Interventions

Intervention1: Dexmeditomidine 50mcgs: Post operative analgesia after using as an adjuvant with 0.5% bupivacaine 5ml for 24 hours will be monitored every one hour Control Intervention1: Dexamethasone

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients scheduled toundergo elective thyroid surgeries under general anesthesia. 2. Patients of ASA physical status I & 1. 3. Patients of either sex aged 16 to 60 years.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
To compare the adjuvant effect of duration of post op analgesia with DEXMEDETOMIDINE (group A)versus DEXAMETHASONE(group B) when added with 0.2% ropivacaine in terms of total duration of analgesia.Timepoint: To assess the pain by VAS score post operatively every hour for 24 hours	—

Secondary

Measure	Time frame
To compare the intraoperative hemodynamic parameters between two groupsTimepoint: To assess the hemodynamic parameter intra operatively by measurement of heart rate and blood pressure for every 5mins for 3hours	—

Countries

India

Contacts

Public ContactDilip Chandar D

Sri manakula vinayagar medical college and hospital

dilipchandar2000@gmail.com9993031202

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026